Sign in

CIK 0000873303

  • Large accelerated filer

Sarepta Therapeutics, Inc.

Sign in to watch
Ticker
SRPT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
930797222
Phone
+1 617-274-4000
Business address
215 FIRST STREET, SUITE 415, CAMBRIDGE, MA, 02142
Former names
Sarepta Therapeutics, Inc., AVI BIOPHARMA INC, ANTIVIRALS INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Shares withheld for taxes Chief Financial Officer gave up 2,613 shares (to pay taxes)
  4. 4 Gift Chief Financial Officer gave 250 shares (gift)
  5. 4 Open-market sale Director sold 10,500 shares at $124.84 ($1,310,820)
  6. 4 Open-market sale Director sold 1,636 shares at $125.55 ($205,400)
  7. 4 Grant or award EVP, General Counsel acquired 2,000 shares (grant or award)
  8. 3 Insider Initial Statement of Ownership
  9. 4 Shares withheld for taxes Head of R&D, CSO gave up 4,558 shares (to pay taxes)
  10. 4 Grant or award Director acquired 2,842 shares (grant or award)
  11. 3 Insider Initial Statement of Ownership
  12. 4 Gift Director gave 746 shares (gift)
  13. 4 Open-market sale Chief Financial Officer sold 5,985 shares at $137.36 ($822,100)
  14. 4 Open-market buy Director bought 37,038 shares at an average $133.80 ($4,955,728)
  15. 4 Exercise or conversion Director acquired 15,000 shares (option exercise)
  16. 4 Planned sale EVP, General Counsel sold 38,957 shares at an average $161.61 ($6,296,029)
  17. 4 Shares withheld for taxes Head of R&D, CSO gave up 2,182 shares (to pay taxes)
  18. 4 Shares withheld for taxes Chief Customer Officer gave up 2,352 shares (to pay taxes)
  19. 4 Shares withheld for taxes Chief Financial Officer gave up 2,483 shares (to pay taxes)
  20. 4 Planned sale Chief Tech Ops Officer sold 11,757 shares at an average $163.13 ($1,917,891)

Page 5 of 34 · 672 filings